- Datum17.03.2025
- Uhrzeit08:00 - 09:00 Uhr
- Veranstalter
XTB
Kein Moderator verfügbar
Siegfried Holding AG Aktie
Verkaufen
Kaufen
Siegfried Holding AG Chart
Siegfried Holding AG Realtime-Kurs
| Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Baader | VK | |||||
| L&S weekend | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (SIX)
1,36 %
Intraday
-3,03 %
1 Woche
-15,73 %
1 Monat
-9,23 %
Seit Jahresbeginn
-2,77 %
1 Jahr
20,30 %
3 Jahre
165,19 %
5 Jahre
516,39 %
10 Jahre
Wikifolio
Passender Service zu Siegfried Holding AG
Webinar zu Siegfried Holding AG
Kursinformationen (SIX)
- Tagestief / Hoch (Fr)-
- 52W-Tief / Hoch (Fr)843,000-1.188,000
- Jahrestief / Hoch (Fr)876,000-1.074,000
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Siegfried Holding AG
| Ex-Datum | Fiskaljahr | Dividende | Rendite |
|---|---|---|---|
| - | 2028 (e) | ||
| - | 2027 (e) | ||
| - | 2026 (e) | ||
| - | 2025 (e) | ||
| - | 2024 (e) | ||
| - | 2023 (e) | ||
| 15.04.2009 | 2008 | 2,10 Fr | 3,50 % |
| 16.04.2008 | 2007 | 4,20 Fr | 2,76 % |
| 18.04.2007 | 2006 | 4,20 Fr | 2,22 % |
| 12.04.2006 | 2005 | 4,20 Fr | 2,03 % |
| 20.04.2005 | 2004 | 3,50 Fr | 2,27 % |
| 13.05.2004 | 2003 | 5,00 Fr | 2,96 % |
| 14.05.2003 | 2002 | 5,00 Fr | 2,91 % |
| 16.05.2001 | 2000 | 12,50 Fr | - |
| 16.05.2000 | 1999 | 12,50 Fr | - |
| 28.04.1999 | 1998 | 12,50 Fr | - |
| 29.04.1998 | 1997 | 12,50 Fr | - |
| 28.05.1997 | 1996 | 12,50 Fr | - |
| 26.06.1996 | 1995 | 12,50 Fr | - |
| 21.06.1995 | 1994 | 12,50 Fr | - |
| 21.06.1994 | 1993 | 25,00 Fr | - |
Termine von Siegfried Holding AG
- Aug21Siegfried Holding AGQ2 2025 Earnings Release
- Feb25Siegfried Holding AGQ4 2025 Earnings Release
- Aug20Siegfried Holding AGQ2 2026 Earnings Release
Beschreibung
Siegfried Holding AG engages in the life sciences business worldwide. The company develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling injectables, ophthalmics, and inhalative products. It offers contract development and manufacturing services, including pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale up and clinical trial material production. In addition, the company provides APIs and controlled substances focusing on anesthetics, pain treatment applications, and central nervous and respiratory diseases. Further, it licenses oral solid and sterile products; assembles registration dossiers; and offers a common technical document for various products. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.
